--- title: "Paul Tudor Jones And Israel Englander Are Both In This Oil Stock — Now A Golden Cross Appears" type: "News" locale: "en" url: "https://longbridge.com/en/news/278749490.md" description: "Paul Tudor Jones and Israel Englander are investing in EOG Resources, which has recently shown a bullish golden cross on its chart. The stock is up over 19% year-to-date, nearing its 52-week high. Jones' Tudor Investment Corporation holds about 355,000 shares, while Englander's Millennium Management owns approximately 1.5 million shares. EOG's strong fundamentals, including a diversified shale portfolio and robust cash flow, support this technical breakout, making it a focal point for investors in the energy sector." datetime: "2026-03-11T15:35:07.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/278749490.md) - [en](https://longbridge.com/en/news/278749490.md) - [zh-HK](https://longbridge.com/zh-HK/news/278749490.md) generator: "portal-rs" --- # Paul Tudor Jones And Israel Englander Are Both In This Oil Stock — Now A Golden Cross Appears Oil stocks have quietly crept back onto investors' radar this year, but one name is drawing attention from both billionaire hedge funds and technical traders at the same time: **EOG Resources, Inc.** (NYSE:EOG) The $68 billion shale producer recently climbed toward its 52-week high of $134.36, closing Tuesday at $127.89. Even after a volatile month for energy markets, the stock remains up more than 19% year-to-date, signaling persistent investor interest. And now, the chart may be adding fuel to the story. *Chart created using Benzinga Pro* ## Billionaire Hedge Funds Are Already In EOG Stock Some prominent hedge fund managers appear to have positioned themselves ahead of the recent rally. Macro investor **Paul Tudor Jones**' **Tudor Investment Corporation** owns about 355,000 shares valued at nearly $37 million, increasing the position in the 13F filing for Q4 2025. Meanwhile, **Israel Englander**'s **Millennium Management** holds roughly 1.5 million shares worth around $155 million, boosting its stake by more than 21% as of Dec. 31, 2025. ## EOG Golden Cross Adds Bullish Momentum At the same time, EOG's chart has flashed a widely watched technical signal. The stock recently formed a **Golden Cross**, which occurs when the 50-day moving average rises above the 200-day moving average. Many traders interpret the pattern as a sign that long-term momentum is turning bullish. Momentum indicators also appear constructive, with RSI (relative strength index) in the low-60s and MACD (moving average convergence/divergence) remaining positive, suggesting buying pressure has stayed intact even as oil prices cooled. ## Strong Fundamentals Behind The Move Beyond the chart, EOG's fundamentals remain a key part of the story. The company's diversified U.S. shale portfolio, low-cost operations, and expanding natural gas assets continue to generate strong free cash flow and double-digit return on capital employed. In other words, this isn't just a technical breakout. With billionaire hedge funds already positioned and a fresh golden cross on the chart, EOG Resources is quickly becoming one of the more closely watched energy stocks on investors' screens. *Image created using artificial intelligence via ChatGPT.* ### Related Stocks - [EOG.US](https://longbridge.com/en/quote/EOG.US.md) - [XOP.US](https://longbridge.com/en/quote/XOP.US.md) - [IXC.US](https://longbridge.com/en/quote/IXC.US.md) - [USO.US](https://longbridge.com/en/quote/USO.US.md) - [XLE.US](https://longbridge.com/en/quote/XLE.US.md) - [OIH.US](https://longbridge.com/en/quote/OIH.US.md) - [IEO.US](https://longbridge.com/en/quote/IEO.US.md) ## Related News & Research - [India extends duty-free cotton imports by two months to ease domestic prices](https://longbridge.com/en/news/303818982.md) - [Dodla Dairy Limited (NSE:DODLA) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year](https://longbridge.com/en/news/303820105.md) - [SPIRIT-E project concludes that e-trucks can serve as mobile power banks](https://longbridge.com/en/news/303829814.md) - [Zhimeng Biopharma has completed the patients enrollment of its investigational drug, CB03-154, in the pivotal Phase 2/3 ALS clinical trial.](https://longbridge.com/en/news/303820254.md) - [BIKE Subsidiary Karya Bersinar Indonesia Wins Rp 3.8 Trillion Power Plant Contract From PLN Indonesia Power](https://longbridge.com/en/news/303818847.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**